Circulating chemokine (C-X-C Motif) receptor 5+CD4+ T cells benefit hepatitis B e antigen seroconversion through IL-21 in patients with chronic hepatitis B virus infection
Hepatology2013Vol. 58(4), pp. 1277–1286
Citations Over TimeTop 10% of 2013 papers
Yongyin Li, Shiwu Ma, Libo Tang, Yun Li, Wei Wang, Xuan Huang, Qintao Lai, Mingxia Zhang, Jian Sun, Chris Ka-fai Li, William G.H. Abbott, Nikolai V. Naoumov, Yu Zhang, Jinlin Hou
Abstract
Circulating CXCR5(+) CD4(+) T cells, by producing IL-21, may have a significant role in facilitating HBeAg seroconversion in patients with chronic HBV infection.
Related Papers
- → Relationship between hepatitis B core‐related antigen levels and sustained HBeAg seroconversion in patients treated with nucleo(s)tide analogues(2019)20 cited
- Changes over time in post-seroconversion CD4 cell counts in the Italian HIV-Seroconversion Study: 1985-2002.(2005)
- → Comparison of Seroconversion Rates with Three Kinds of Recombinant Hepatitis B Vaccines(1999)2 cited
- → Serological Markers of Primary HIV Infection(1989)4 cited
- → High anti-SARS-CoV-2 antibody seroconversion rates before the second wave in Manaus, Brazil, and the protective effect of social behavior measures: Results from the DETECTCoV-19 cohort.(2021)2 cited